Effects of dance and music on brain health in older adults at risk for Alzheimer's
Official title: Establishing the Optimal Frequency of Dance Movement for Neurocognitive and Physical Outcomes in People at Risk of Alzheimer's Disease
Run by Wake Forest University Health Sciences · NCT05507905 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study tests if dance and music classes can help improve memory and fitness in older adults who are worried about Alzheimer's.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | Wake Forest University Health Sciences Academic / other |
| Locations | 1 site (Winston-Salem, North Carolina) |
| Trial ID | NCT05507905 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults aged 65 and older who are low-active and concerned about their memory but do not have cognitive impairment.
✕Probably not a fit
Patients with a current diagnosis of major neurological disorders or those unable to participate in the classes will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research investigates how dance movement and music appreciation can enhance memory and cardiorespiratory fitness in older adults concerned about memory loss. Participants aged 65 and older, who do not have a diagnosis of cognitive impairment, will be randomized into groups attending 1, 2, or 3 classes per week for 24 weeks. The study will include clinical assessments, such as brain MRIs, to evaluate the impact of these interventions on brain health. Classes will be conducted by local experts in accessible community locations.
Why it matters
Potential benefit: If successful, this study could improve cognitive function and overall fitness in older adults at risk for Alzheimer's disease.
How similar studies have gone: Other studies have shown positive effects of physical activity and music on cognitive health, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cognitive Change Index score ≥16 * Montreal Cognitive Assessment (MoCA) score ≥21 * Cognitively normal * Low-active for past 6 months (\<30 min, 3 days/week of exercise, including walking for exercise) * MRI compatible * Willing and able to complete exercise testing. * Has reliable transportation or is able to use transportation provided by the study. * English speaking (needed for group class participation) Exclusion Criteria: * Unable or unwilling to attend intervention classes 1-3x/week * Current diagnosis of a major neurological disorder (Alzheimer's disease, Lewy body dementia, Frontotemporal dementia, Parkinson's disease, amyotrophic lateral sclerosis, etc.) * Unwilling or unable to provide consent for study participation. * Currently symptomatic or cortical stroke or stroke deemed exclusionary by the study physician. Reported or observed evidence of strokes on MRI will be reviewed on a case-by-case basis by the study physician to assess factors such as location, size, time since stroke, and residual symptoms. * Taking medication during the intervention times that could negatively influence safety * Current cancer treatment or other major medical problems that might independently affect cognition or movement or interfere with ability to attend intervention or study visits. * Chronic vertigo. * Enrolled in another interventional research study ≤3 months prior to beginning this study. * Hip fracture, hip or knee replacement, or spinal surgery in past 6 months. * Health contraindications for completing a graded exercise test and movement intervention, including uncontrolled hypertension (BP\>200/110 mmHg), hypertriglyceridemia (TG\>400 mg/dl), uncontrolled diabetes (HbA1c \> 7.5), clinical evidence of anemia. * Self-reports regularly drinking \> 14 alcoholic beverages a week or current illicit drug use. * Unable or unwilling to understand study procedures and comply with them for the duration of the study.
Where it's running
-
Wake Forest School of Medicine
Winston-Salem, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Christina Hugenschmidt, PhD — Wake Forest University Health Sciences
- Study coordinator: Christina Hugenschmidt, PhD
- Email: chugensc@wakehealth.edu
- Phone: 336-713-4190
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
-
Tau changes after hip or knee replacement surgery
Researchers will see if brain tau changes after hip or knee surgery and whether these changes relate to inflammation and thinking abilities.
-
Low-Dose Whole-Brain Radiation Therapy With HeLaXON 1X in Mild Alzheimer's Dementia
This study will test whether a low-dose brain radiation treatment using HeLaXON helps people with mild Alzheimer's dementia improve or stabilize thinking and daily function.
-
Cervical lymphatic surgery to see if it helps people with mild Alzheimer’s
We’re testing a surgical approach in people with mild Alzheimer’s to see if creating alternative neck lymph drainage routes can affect brain biomarkers and daily function.
-
Transcranial random noise stimulation for behavioral and psychological symptoms in Alzheimer's disease
This trial tests whether high-frequency transcranial random noise stimulation can help people with early Alzheimer's disease who have BPSD, compared to a sham treatment.
-
Testing LY4405094 in healthy people and people with Alzheimer’s disease
This study tests LY4405094 to see if it is safe and how it behaves in the body, including how it reaches the brain fluid in healthy participants and how it affects a brain protein in people with Alzheimer's disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.